Mercator Medical SA
F:MM2
Balance Sheet
Balance Sheet Decomposition
Mercator Medical SA
Mercator Medical SA
Balance Sheet
Mercator Medical SA
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
3
|
13
|
6
|
8
|
22
|
21
|
16
|
15
|
400
|
340
|
223
|
217
|
123
|
|
| Cash |
1
|
1
|
2
|
2
|
6
|
8
|
21
|
0
|
12
|
13
|
395
|
338
|
67
|
63
|
35
|
|
| Cash Equivalents |
0
|
1
|
2
|
11
|
0
|
0
|
2
|
21
|
4
|
2
|
5
|
1
|
157
|
154
|
88
|
|
| Total Receivables |
17
|
22
|
18
|
22
|
0
|
0
|
41
|
48
|
79
|
84
|
340
|
126
|
71
|
105
|
170
|
|
| Accounts Receivables |
17
|
21
|
18
|
20
|
26
|
35
|
40
|
0
|
76
|
81
|
332
|
117
|
61
|
72
|
109
|
|
| Other Receivables |
1
|
1
|
0
|
2
|
0
|
0
|
1
|
0
|
2
|
3
|
8
|
8
|
10
|
33
|
61
|
|
| Inventory |
14
|
23
|
19
|
27
|
0
|
0
|
54
|
74
|
97
|
89
|
207
|
230
|
201
|
148
|
213
|
|
| Other Current Assets |
1
|
1
|
2
|
2
|
0
|
3
|
7
|
0
|
1
|
3
|
149
|
219
|
202
|
115
|
129
|
|
| Total Current Assets |
33
|
47
|
43
|
64
|
0
|
3
|
124
|
143
|
193
|
191
|
1 096
|
914
|
698
|
585
|
635
|
|
| PP&E Net |
26
|
29
|
30
|
33
|
0
|
0
|
78
|
138
|
176
|
189
|
183
|
336
|
285
|
255
|
311
|
|
| PP&E Gross |
26
|
29
|
30
|
0
|
0
|
0
|
78
|
0
|
176
|
189
|
183
|
336
|
285
|
255
|
311
|
|
| Accumulated Depreciation |
11
|
14
|
16
|
0
|
0
|
26
|
34
|
0
|
53
|
73
|
86
|
99
|
123
|
249
|
216
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
4
|
4
|
10
|
25
|
33
|
32
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
46
|
68
|
36
|
|
| Other Long-Term Assets |
1
|
2
|
3
|
3
|
0
|
0
|
4
|
5
|
4
|
3
|
6
|
28
|
30
|
24
|
30
|
|
| Total Assets |
60
N/A
|
77
+28%
|
76
-2%
|
100
+32%
|
0
N/A
|
0
N/A
|
208
N/A
|
289
+39%
|
376
+30%
|
387
+3%
|
1 289
+233%
|
1 289
0%
|
1 083
-16%
|
965
-11%
|
1 043
+8%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
6
|
17
|
10
|
7
|
22
|
26
|
34
|
0
|
82
|
89
|
100
|
57
|
36
|
53
|
77
|
|
| Accrued Liabilities |
0
|
1
|
1
|
2
|
0
|
0
|
3
|
2
|
6
|
8
|
110
|
44
|
13
|
10
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
27
|
27
|
25
|
24
|
0
|
0
|
30
|
30
|
66
|
51
|
2
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
1
|
1
|
4
|
0
|
0
|
3
|
74
|
8
|
5
|
27
|
31
|
10
|
14
|
8
|
|
| Total Current Liabilities |
34
|
47
|
37
|
37
|
22
|
26
|
70
|
105
|
162
|
153
|
240
|
133
|
60
|
78
|
97
|
|
| Long-Term Debt |
10
|
10
|
11
|
3
|
0
|
0
|
11
|
60
|
84
|
97
|
2
|
4
|
2
|
4
|
3
|
|
| Deferred Income Tax |
1
|
2
|
2
|
2
|
0
|
0
|
3
|
3
|
2
|
1
|
3
|
4
|
9
|
21
|
16
|
|
| Minority Interest |
4
|
3
|
4
|
3
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
1
|
0
|
2
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
3
|
|
| Total Liabilities |
49
N/A
|
61
+24%
|
55
-11%
|
47
-15%
|
0
N/A
|
0
N/A
|
86
N/A
|
170
+99%
|
249
+46%
|
254
+2%
|
249
-2%
|
145
-42%
|
74
-49%
|
103
+39%
|
115
+12%
|
|
| Equity | ||||||||||||||||
| Common Stock |
2
|
2
|
7
|
9
|
0
|
0
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
10
|
|
| Retained Earnings |
3
|
7
|
8
|
40
|
0
|
0
|
100
|
101
|
109
|
106
|
964
|
1 079
|
888
|
855
|
895
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
57
|
58
|
58
|
31
|
31
|
|
| Unrealized Security Profit/Loss |
5
|
5
|
4
|
4
|
5
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
2
|
2
|
1
|
0
|
0
|
7
|
2
|
8
|
16
|
8
|
3
|
52
|
34
|
7
|
|
| Total Equity |
11
N/A
|
16
+46%
|
21
+33%
|
54
+156%
|
0
N/A
|
0
N/A
|
122
N/A
|
118
-3%
|
127
+7%
|
133
+5%
|
1 040
+681%
|
1 144
+10%
|
1 009
-12%
|
862
-15%
|
928
+8%
|
|
| Total Liabilities & Equity |
60
N/A
|
77
+28%
|
76
-2%
|
100
+32%
|
0
N/A
|
0
N/A
|
208
N/A
|
289
+39%
|
376
+30%
|
387
+3%
|
1 289
+233%
|
1 289
0%
|
1 083
-16%
|
965
-11%
|
1 043
+8%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
7
|
9
|
0
|
0
|
11
|
11
|
11
|
11
|
10
|
10
|
10
|
10
|
10
|
|